UBS Group AG - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 123 filers reported holding INTERSECT ENT INC in Q1 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$641,000
-24.9%
22,891
-26.8%
0.00%
Q4 2021$854,000
+135.3%
31,259
+134.6%
0.00%
Q3 2021$363,000
-92.1%
13,323
-95.0%
0.00%
-100.0%
Q2 2021$4,570,000
-39.3%
267,415
-25.8%
0.00%
-50.0%
Q1 2021$7,529,000
-74.7%
360,571
-72.3%
0.00%
-80.0%
Q4 2020$29,777,000
+29.2%
1,300,336
-8.0%
0.01%
+11.1%
Q3 2020$23,056,000
-22.3%
1,413,617
-35.5%
0.01%
-30.8%
Q2 2020$29,674,000
+14.4%
2,191,611
+0.1%
0.01%
+8.3%
Q1 2020$25,933,000
-30.0%
2,188,412
+47.1%
0.01%
-7.7%
Q4 2019$37,035,000
+56.6%
1,487,366
+7.0%
0.01%
+44.4%
Q3 2019$23,644,000
+42121.4%
1,389,980
+56449.2%
0.01%
Q2 2019$56,000
+12.0%
2,458
+59.6%
0.00%
Q1 2019$50,000
-88.0%
1,540
-89.5%
0.00%
Q4 2018$415,000
+865.1%
14,696
+866.2%
0.00%
Q3 2018$43,000
-85.7%
1,521
-81.1%
0.00%
Q2 2018$301,000
+63.6%
8,034
+71.7%
0.00%
Q1 2018$184,000
+119.0%
4,679
+81.1%
0.00%
Q4 2017$84,000
-23.6%
2,583
-26.9%
0.00%
Q3 2017$110,000
+74.6%
3,535
+57.4%
0.00%
Q2 2017$63,000
+18.9%
2,246
-26.9%
0.00%
Q1 2017$53,000
-26.4%
3,073
-48.3%
0.00%
Q4 2016$72,000
+140.0%
5,947
+212.2%
0.00%
Q3 2016$30,000
-31.8%
1,905
-42.9%
0.00%
Q2 2016$44,000
-27.9%
3,337
+4.2%
0.00%
Q1 2016$61,000
+74.3%
3,204
+101.8%
0.00%
Q4 2015$35,000
+9.4%
1,588
+16.3%
0.00%
Q3 2015$32,000
+33.3%
1,365
+4.4%
0.00%
Q4 2014$24,0001,3080.00%
Other shareholders
INTERSECT ENT INC shareholders Q1 2020
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders